Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy

The response to neoadjuvant chemotherapy in breast cancer patients is usually assessed by pCR and RCB score. However, the prognostic value of these parameters is still in discussion. We showed recently that an epirubicin/docetaxel therapy is associated with an increase in the cell death marker high‐...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Med
Autori principali: Exner, Ruth, Sachet, Monika, Arnold, Tobias, Zinn‐Zinnenburg, Mercedes, Michlmayr, Anna, Dubsky, Peter, Bartsch, Rupert, Steger, Guenther, Gnant, Michael, Bergmann, Michael, Bachleitner‐Hofmann, Thomas, Oehler, Rudolf
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2016
Soggetti:
Clinical Cancer Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5055166/
https://ncbi.nlm.nih.gov/pubmed/27457217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.827
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi